Zhiping Weng

Co-Founder & Head of SAB at Rgenta Therapeutics

Dr. Weng is a Professor and Director of Program in Bioinformatics and Integrative Biology and Endowed Chair at the University of Massachusetts Medical School. She has published more than 250 scientific papers, with a total citation of more than 50,000 and an H-index of 95 as of March 2020. She was elected a Fellow of the American Institute for Medical and Biological Engineering in 2013 and a Fellow of the International Society of Computational Biology in 2020. Dr. Weng’s scientific research and biomedical investigations focus on genomics, epigenomics, transcriptomics, and molecular recognition. Her laboratory develops and applies cutting-edge computational and statistical methods to study biological problems with large amounts of data. A national and international leader in large-scale epigenomic sciences, Dr. Weng has led the Data Analysis Center of the ENCODE Consortium since 2012 and co-led the Data Analysis Center of the PsychENCODE Consortium since 2015. The goals of these two consortia are to investigate the regulatory landscapes in the human genome, with ENCODE focusing on normal physiology and PsychENCODE on psychiatric disorders.

Timeline

  • Co-Founder & Head of SAB

    Current role

  • Scientific Advisor